Travere Therapeutics, Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Stronger technical forecast for Travere Therapeutics, Inc. stock price after Monday trading.
(Updated on May 06, 2024)
The Travere Therapeutics, Inc. stock price gained 4.63% on the last trading day (Monday, 6th May 2024), rising from $6.26 to $6.55. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 5.88% from a day low at $6.21 to a day high of $6.58. The price has risen in 6 of the last 10 days and is up by 11.97% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 581 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $8.77 million.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $6.64 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -31.64% during the next 3 months and, with a 90% probability hold a price between $3.39 and $4.54 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TVTX Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 24.52%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Travere Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $6.62. On a fall, the stock will find some support from the short-term average at $5.89. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $6.00 and $5.46. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Travere Therapeutics, Inc. finds support just below today's level at $6.00. If this is broken, then the next support from accumulated volume will be at $5.46 and $5.39.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.365 between high and low, or 5.88%. For the last week, the stock has had daily average volatility of 7.63%.
Since the Travere Therapeutics, Inc. has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.
Our recommended stop-loss: $6.30 (-3.84%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (TVTX) For The Upcoming Trading Day Of Tuesday 7th
For the upcoming trading day on Tuesday, 7th we expect Travere Therapeutics, Inc. to open at $6.45, and during the day (based on 14 day Average True Range), to move between $6.15 and $6.95, which gives a possible trading interval of +/-$0.396 (+/-6.05%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.10% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $6.67 (1.83%) than the support at $6.00 (8.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Travere Therapeutics, Inc. stock A Buy?
Travere Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: -0.336 Hold/Accumulate Upgraded
Predicted Opening Price for Travere Therapeutics, Inc. of Tuesday, May 7, 2024
| Fair opening price May 7, 2024 | Current price |
|---|---|
| $6.45 ( 1.60%) | $6.55 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TVTX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 6.81 | 3.97 % | |
| R2 | 6.67 | 1.84 % | ||
| R1 | 6.58 | 0.526 % | ||
| Current price: | 6.55 | |||
| Support | S1 | 6.31 | -3.73 % | |
| S2 | 6.22 | -5.05 % | ||
| S3 | 6.08 | -7.18 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 7.99 | 21.98 % | |
| R2 | 7.88 | 20.31 % | ||
| R1 | 6.67 | 1.83 % | ||
| Current price | 6.55 | |||
| Support | S1 | 6.00 | -8.40% | |
| S2 | 5.46 | -16.64% | ||
| S3 | 5.39 | -17.71% |
FAQ
Click here for our free guide on how to buy Travere Therapeutics, Inc. Stock.
